Schedule 13G ownership disclosure
Intellia Therapeutics Inc
Common Stock · CUSIP: 45826J105
Event date: 2024-12-31
- Filing-level shares
- 10,189,953
- Percent of class
- 10%
- The Vanguard Group
Shares: 10,189,953 · Class: 10%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000028
- Form type
- SCHEDULE 13G/A
- Filer
- Intellia Therapeutics, Inc.
- CIK
- CIK 1652130
- Filed
- Jan 08, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership